Production (Stage)
Calidi Biotherapeutics, Inc.
CLDI
$0.31
-$0.01-3.13%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.11% | 405.59% | 126.91% | -26.86% | -41.35% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.19% | 396.30% | -73.13% | -26.78% | -75.64% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 182.00% | -53.70% | 4.85% | -15.57% | 144.00% |
| Total Current Assets | 12.34% | 360.47% | 36.68% | -16.06% | -55.01% |
|
|
|||||
| Total Current Assets | 12.34% | 360.47% | 36.68% | -16.06% | -55.01% |
| Net Property, Plant & Equipment | -9.78% | -9.86% | -7.86% | -7.74% | -7.11% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -5.26% | -29.95% | -4.41% | -55.14% | 35.66% |
| Total Assets | 6.22% | 113.04% | 3.51% | -13.15% | -26.09% |
|
|
|||||
| Total Accounts Payable | -41.90% | -41.97% | -21.40% | 16.62% | 35.52% |
| Total Accrued Expenses | -40.59% | -16.94% | -13.39% | -25.71% | 2.52% |
| Short-term Debt | -- | 3.27% | 3.38% | -41.58% | 43.67% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -38.24% | 2.82% | 3.73% | -19.48% | 231.78% |
| Total Finance Division Other Current Liabilities | -- | -- | -50.00% | 100.00% | -- |
| Total Other Current Liabilities | -- | -- | -50.00% | 100.00% | -- |
| Total Current Liabilities | -42.86% | -17.99% | -11.29% | -12.71% | 46.14% |
|
|
|||||
| Total Current Liabilities | -42.86% | -17.99% | -11.29% | -12.71% | 46.14% |
| Long-Term Debt | 0.00% | -74.72% | 23.27% | -42.96% | 63.83% |
| Short-term Debt | -- | 3.27% | 3.38% | -41.58% | 43.67% |
| Capital Leases | -16.98% | -14.48% | -11.89% | -10.57% | -9.22% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -32.03% | -27.27% | -68.85% | -18.94% | -74.27% |
| Total Liabilities | -36.43% | -25.77% | -9.50% | -17.27% | 20.40% |
|
|
|||||
| Common Stock & APIC | 8.43% | 14.77% | 6.52% | 9.35% | 0.91% |
| Retained Earnings | -4.10% | -3.48% | -4.49% | -5.40% | -7.26% |
| Treasury Stock & Other | 7.14% | 62.16% | -174.07% | -345.45% | 123.40% |
| Total Common Equity | 352.48% | 114.92% | 12.50% | 19.36% | -76.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 352.48% | 114.92% | 12.50% | 19.36% | -76.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -17.51% | -10.52% | -- | -- | -- |
| Total Equity | 270.88% | 120.09% | 16.63% | 19.36% | -76.96% |
|
|
|||||